Vaccine News and Research

Latest Vaccine News and Research

New clues about B. burgdorferi could lead to novel strategy to reduce Lyme disease

New clues about the bacteria that cause Lyme disease could lead to a novel strategy to reduce infections, according to a study to be published in mBio-, the online open-access journal of the American Society for Microbiology, on December 4.

4 Dec 2012

Data from OncoSec Medical clinical studies to be presented at DNA Vaccines 2012 Conference

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference.

4 Dec 2012

Hebrew University researchers pave way for development of new approaches to cure malaria

More than a million people die each year of malaria caused by different strains of the Plasmodium parasite transmitted by the Anopheles mosquito. The medical world has yet to find an effective vaccine against the deadly parasite, which mainly affects pregnant women and children under the age of five. By figuring out how the most dangerous strain evades the watchful eye of the immune system, researchers from the Hebrew University of Jerusalem have now paved the way for the development of new approaches to cure this acute infection.

4 Dec 2012

Virginia Women's Center to participate in new HPV and cervical cancer vaccine clinical trial

Virginia Women's Center has been selected to participate in a nationwide clinical trial, one that will ultimately hope to prevent the human papillomavirus virus (HPV) from progressing into cervical cancer and treat women who have HPV and the precancerous lesions associated with it. The Richmond-area OB-GYN practice has participated in over 50 clinical research studies since 1997, all of which have contributed to the future of safe and effective medicine for women.

4 Dec 2012

Showing progress in the 'decade of vaccines'

In a post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Christopher Elias, president of global development at the foundation, discusses progress on "the Decade of Vaccines, a vision and commitment to reach all people with the vaccines they need."

4 Dec 2012

PBS blog interviews journalist Jon Cohen about progress against HIV/AIDS

The PBS NewsHour's "The Rundown" blog features an interview with journalist Jon Cohen, in which he discusses the possibility of an "AIDS-free generation," recent reports from UNAIDS and the Centers for Disease Control and Prevention, AIDS funding, HIV vaccine research, and World AIDS Day.

4 Dec 2012

Certain patients with prostate cancer may benefit from Provenge clinical trial

Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.

4 Dec 2012

Colleges and universities should implement new or improved flu vaccine strategies

College football and basketball games may provide more than a way for students to show school spirit - they could help prevent the flu.

3 Dec 2012

University of Washington team develops electrically spun cloth to prevent pregnancy, HIV

The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations.

1 Dec 2012

Scientists can produce new proteins by following certain rules

By following certain rules, scientists can prepare architectural plans for building ideal protein molecules not found in the real world. Based on these computer renditions, previously non-existent proteins can be produced from scratch in the lab. The principles to make this happen appear this month in Nature magazine.

1 Dec 2012

DFG to establish 11 Collaborative Research Centres in Jan 2013

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eleven Collaborative Research Centres (CRCs) as of 1 January 2013. This was decided by the responsible Grants Committee during its fall session in Bonn.

30 Nov 2012

Membrane-proximal external region of HIV could be used to design vaccines

Beatriz Apellaniz, PhD holder of the UPV/EHU-University of the Basque Country, has studied in her PhD thesis HIV regions that could be used to design a vaccine. The researcher has focussed her research on a specific region of the surface protein of the Human Immunodeficiency Virus (HIV), which is responsible for the Autoimmune Deficiency Syndrome (AIDS), one of the diseases with the greatest human morbidity and mortality.

30 Nov 2012

Tdap well tolerated in over-65s

Off-label use of tetanus–diptheria–acellular pertussis vaccine in senior patients results in no more adverse events than the tetanus and diphtheria vaccine, a US study shows.

30 Nov 2012

Blog examines report on state of TB funding

Writing in the Global Health Technologies Coalition's "Breakthroughs" blog, Eleonora Jimenez-Levi, a senior researcher at the Treatment Action Group (TAG), examines the 2012 Report on Tuberculosis Research Funding Trends: 2005–2011,"the latest report on the state of funding for tuberculosis (TB) research and product development."

30 Nov 2012

VAC-3S immunotherapeutic vaccine for HIV completes first clinical development phase

InnaVirVax, a biopharmaceutical company specialized in research and development on therapeutic and diagnostic solutions for diseases linked to immune dysregulation, has just announced successful completion of the first clinical development phase for VAC-3S immunotherapy in the treatment of HIV infections.

30 Nov 2012

Four TSRI scientists named American Association for the Advancement of Science fellows

Four scientists from The Scripps Research Institute (TSRI) have been named fellows of the American Association for the Advancement of Science (AAAS). They are chemist Phil Baran, neuroscientist Hollis Cline, immunologist J. Lindsay Whitton, and chemist Jin-Quan Yu. Election as a AAAS fellow is an honor bestowed upon AAAS members by their peers

30 Nov 2012

Aduro completes enrollment in CRS-207 and GVAX pancreas cancer vaccine Phase 2 trial

Aduro BioTech, Inc. announces completion of enrollment in the Phase 2 clinical trial of the sequential administration of two cancer vaccines, Aduro's CRS-207 and GVAX Pancreas Cancer Vaccine, in patients with metastatic pancreatic cancer.

30 Nov 2012

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

PharmaJet Inc. has entered into a collaboration with CSL Limited to enable Afluria influenza vaccine to be delivered with the PharmaJet Stratis needle-free jet injector, as soon as the 2013-2014 flu season.

30 Nov 2012

Bend Research, PATH and FhCMB develop new technology for thermostable vaccine production

Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.

29 Nov 2012

SLU study to use various assays for new TB vaccine development

A pilot study at Saint Louis University Center for Vaccine Development could shape the future of tuberculosis vaccine research by developing tests to identify the most promising vaccine candidates to address this global health crisis.

29 Nov 2012

Vaccine News and Research

Latest Vaccine News and Research

New clues about B. burgdorferi could lead to novel strategy to reduce Lyme disease

Data from OncoSec Medical clinical studies to be presented at DNA Vaccines 2012 Conference

Hebrew University researchers pave way for development of new approaches to cure malaria

Virginia Women's Center to participate in new HPV and cervical cancer vaccine clinical trial

Showing progress in the 'decade of vaccines'

PBS blog interviews journalist Jon Cohen about progress against HIV/AIDS

Certain patients with prostate cancer may benefit from Provenge clinical trial

Colleges and universities should implement new or improved flu vaccine strategies

University of Washington team develops electrically spun cloth to prevent pregnancy, HIV

Scientists can produce new proteins by following certain rules

DFG to establish 11 Collaborative Research Centres in Jan 2013

Membrane-proximal external region of HIV could be used to design vaccines

Tdap well tolerated in over-65s

Blog examines report on state of TB funding

VAC-3S immunotherapeutic vaccine for HIV completes first clinical development phase

Four TSRI scientists named American Association for the Advancement of Science fellows

Aduro completes enrollment in CRS-207 and GVAX pancreas cancer vaccine Phase 2 trial

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

Bend Research, PATH and FhCMB develop new technology for thermostable vaccine production

SLU study to use various assays for new TB vaccine development

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in